Anticoagulation in AF with Cirrhosis, Trends in Anticoagulation for Acute PE, Beta Blockers for Acute MI with Normal EF, Finerenone for HFpEF, Continuous vs Intermittent Infusion for Antibiotics, Cefepime vs Piperacillin-Tazobactam for Sepsis

About this episode

The episode discusses recent studies in internal medicine focusing on anticoagulation in patients with cirrhosis and atrial fibrillation, the use of unfractionated heparin for acute PE, beta blockers for acute MI, and other important topics.

It's been a long time, but we are back! Apologies on the audio quality from Dr. Jenkins. Apparently he was recording from inside a cardboard box. Today we talk about important, practice changing studies in internal medicine from the last several months. What's the best anticoagulant in patients with cirrhosis and atrial fibrillation? Why do doctors use so much unfractionated heparin for acute PE? Should we still be using beta blockers in patients with acute MI? Does finerenone improve outco...

People in this episode

Hosts: Stephen Jenkins, MD, Austin Rupp, MD

Topics covered

• anticoagulation
• acute pulmonary embolism
• acute myocardial infarction
• heart failure
• sepsis
• internal medicine

Keywords

• anticoagulation
• atrial fibrillation
• acute PE
• beta blockers
• finerenone
• HFpEF
• sepsis
• Cefepime
• Piperacillin-Tazobactam

Mentioned in this episode

Products: anticoagulant, unfractionated heparin, beta blockers, finerenone, Cefepime, Piperacillin-Tazobactam

Places: Cirrhosis, Atrial Fibrillation

More episodes of Last Week in Medicine

• Catheter Directed Fibrinolysis for Acute PE (HI-PEITHO), NEWS2 Plus Procalcitonin Reduces Mortality (PRONTO) · April 7, 2026 · 1h 1m
• Bleeding Risk with Apixaban vs Rivaroxaban for Acute VTE (COBRRA), Left Atrial Appendage Closure vs Medical Therapy for Atrial Fibrillation (CLOSURE-AF) · March 28, 2026 · 36 min
• 2026 ACC/AHA Guidelines for Acute Pulmonary Embolism · March 11, 2026 · 48 min
• Hematopoietic Stem Cell Gene Therapy for Cystinosis · March 3, 2026 · 42 min
• Extended Apixaban for Provoked VTE (HI-PRO), Coffee and Atrial Fibrillation (DECAF), Age-Adjusted D-dimer for DVT, Beta Blockers after MI with Normal EF, Fish Oil for Dialysis (PISCES), Conservative Dialysis for AKI (LIBERATE-D) · February 25, 2026 · 1h 11m
• Semaglutide for CVD in Diabetes, PAD, and MASH, Semaglutide vs Tirzepatide, Normal Saline vs Lactated Ringer's, Oxygen Targets for Intubated Patients, Platelet Transfusion Guidelines, Apixaban vs Rivaroxaban · June 17, 2025 · 1h 5m